COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper

Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

[1]  Jing Liu,et al.  Updated Approaches against SARS-CoV-2 , 2020, Antimicrobial Agents and Chemotherapy.

[2]  P. Klepac,et al.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.

[3]  Jun Li,et al.  Clinical Features of COVID-19 Related Liver Damage , 2020, medRxiv.

[4]  M. Giles,et al.  Factors influencing the uptake of influenza vaccine vary among different groups in the hard‐to‐reach population , 2020, Australian and New Zealand journal of public health.

[5]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[6]  Wei Wang,et al.  COVID-19 in Wuhan: Immediate Psychological Impact on 5062 Health Workers , 2020, medRxiv.

[7]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[8]  Long Jiang Zhang,et al.  Coronavirus Disease 2019 (COVID-19): A Perspective from China , 2020, Radiology.

[9]  Lei Dong,et al.  Kidney impairment is associated with in-hospital death of COVID-19 patients , 2020, medRxiv.

[10]  Jianjun Gao,et al.  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. , 2020, Bioscience trends.

[11]  L. Kaiser,et al.  Covid-19: a puzzle with many missing pieces , 2020, BMJ.

[12]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[13]  W. Ko,et al.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.

[14]  Z. Wang,et al.  A simple laboratory parameter facilitates early identification of COVID-19 patients , 2020, medRxiv.

[15]  Jaegyun Lim,et al.  Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR , 2020, Journal of Korean medical science.

[16]  Guangdi Li,et al.  Therapeutic options for the 2019 novel coronavirus (2019-nCoV) , 2020, Nature Reviews Drug Discovery.

[17]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[18]  Jie Shi,et al.  2019-nCoV epidemic: address mental health care to empower society , 2020, The Lancet.

[19]  C. Fassbender,et al.  The Use of the Methadone/Metabolite Ratio (MMR) to Identify an Individual Metabolic Phenotype and Assess Risks of Poor Response and Adverse Effects: Towards Scientific Methadone Dosing , 2020, Journal of addiction medicine.

[20]  D. Heymann,et al.  COVID-19: what is next for public health? , 2020, The Lancet.

[21]  G. Leung,et al.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study , 2020, The Lancet.

[22]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[23]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[24]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[25]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[26]  H. Ekhtiari,et al.  The Evolution of Addiction Treatment and Harm Reduction Programs in Iran: A Chaotic Response or a Synergistic Diversity? , 2019, Addiction.

[27]  B. Sanvicente-Vieira,et al.  Cocaine Use Disorder Is Associated With Changes in Th1/Th2/Th17 Cytokines and Lymphocytes Subsets , 2019, Front. Immunol..

[28]  R. Patton,et al.  Same clinic, different conceptions: Drug users’ and healthcare professionals’ perceptions of how stigma may affect clinical care , 2019, Journal of Applied Social Psychology.

[29]  P. Baldi,et al.  Protein malnutrition impairs the immune control of Trichinella spiralis infection. , 2019, Nutrition.

[30]  M. Ilgen,et al.  Understanding Links among Opioid Use, Overdose, and Suicide. , 2019, The New England journal of medicine.

[31]  D. Ghahremani,et al.  Single high-dose buprenorphine for opioid craving during withdrawal , 2018, Trials.

[32]  Andrea Cipriani,et al.  Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis , 2018, PLoS medicine.

[33]  Marina F Englesakis,et al.  The perioperative patient on buprenorphine: a systematic review of perioperative management strategies and patient outcomes , 2018, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[34]  A. Bermejo-Barrera,et al.  Suicidal intentionality among deaths due to acute reaction after drug consumption: A five-year follow-up study , 2018, European Neuropsychopharmacology.

[35]  T. Briese,et al.  Waterpipe smoking as a public health risk: Potential risk for transmission of MERS-CoV , 2018, Saudi Journal of Biological Sciences.

[36]  R. Sinha,et al.  Central and Peripheral Biomarkers of Stress Response for Addiction Risk and Relapse Vulnerability. , 2018, Trends in molecular medicine.

[37]  R. Goodwin,et al.  Cigarette smoking quit rates among adults with and without alcohol use disorders and heavy alcohol use, 2002-2015: A representative sample of the United States population. , 2017, Drug and alcohol dependence.

[38]  A. Gasbarrini,et al.  Alcoholic cardiomyopathy: What is known and what is not known. , 2017, European journal of internal medicine.

[39]  J. Strang,et al.  Contingency Management interventions for non-prescribed drug use during treatment for opiate addiction: A systematic review and meta-analysis , 2017, Drug and alcohol dependence.

[40]  N. Volkow,et al.  Drug use disorders: impact of a public health rather than a criminal justice approach , 2017, World psychiatry : official journal of the World Psychiatric Association.

[41]  B. J. Visser,et al.  Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review. , 2017, The Lancet. Infectious diseases.

[42]  B. J. Visser,et al.  Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature. , 2017, The Lancet. Infectious diseases.

[43]  Xing Liu,et al.  Tobacco and alcohol use among drug users receiving methadone maintenance treatment: a cross-sectional study in a rural prefecture of Yunnan Province, Southwest China , 2017, BMJ Open.

[44]  H. Nam,et al.  High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea , 2017, International Journal of Infectious Diseases.

[45]  H. Balkhy,et al.  An assessment of the level of concern among hospital-based health-care workers regarding MERS outbreaks in Saudi Arabia , 2017, BMC Infectious Diseases.

[46]  L. Pan,et al.  Prevalence and related factors of post-traumatic stress disorder among medical staff members exposed to H7N9 patients , 2016, International Journal of Nursing Sciences.

[47]  A. Lyons,et al.  Opioid Substitution Treatment Planning in a Disaster Context: Perspectives from Emergency Management and Health Professionals in Aotearoa/New Zealand , 2016, International journal of environmental research and public health.

[48]  H. Al-Jahdali,et al.  Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data , 2016, Journal of Epidemiology and Global Health.

[49]  Tianzuo Li,et al.  Opioid System Modulates the Immune Function: A Review , 2016, Translational perioperative and pain medicine.

[50]  Gavin J. M. Entwistle,et al.  Tobacco and e-cigarette use amongst illicit drug users in Australia. , 2016, Drug and alcohol dependence.

[51]  Pardis Nematollahi,et al.  Factors Influencing Access and Use of Care and Treatment Services among Iranian People Living with HIV and AIDS: A Qualitative Study , 2016, Iranian journal of public health.

[52]  Mohammad A. Almazroa,et al.  Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014 , 2016, Emerging infectious diseases.

[53]  J. Montaner,et al.  Pain Among High-Risk Patients on Methadone Maintenance Treatment. , 2015, The journal of pain : official journal of the American Pain Society.

[54]  J. A. Pérez,et al.  A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure. , 2015, Methodist DeBakey cardiovascular journal.

[55]  M. Asghari-Jafarabadi,et al.  Stress Among Iranian Nurses in Critical Wards , 2015, Iranian Red Crescent medical journal.

[56]  S. Hill,et al.  The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. , 2015, Addiction.

[57]  D. Festinger,et al.  Prize-based contingency management for the treatment of substance abusers: a meta-analysis. , 2014, Addiction.

[58]  Robert L Fitzgerald,et al.  False-positive interferences of common urine drug screen immunoassays: a review. , 2014, Journal of analytical toxicology.

[59]  R. Rawson,et al.  Behaviors Influencing Human Immunodeficiency Virus Transmission in the Context of Positive Prevention among People Living with HIV/Acquired Immunodeficiency Syndrome in Iran: A Qualitative Study , 2014, International journal of preventive medicine.

[60]  R. Rawson,et al.  Current Research on Methamphetamine: Epidemiology, Medical and Psychiatric Effects, Treatment, and Harm Reduction Efforts , 2014, Addiction & health.

[61]  G. Koob,et al.  Addiction as a stress surfeit disorder , 2014, Neuropharmacology.

[62]  D. Guha-Sapir,et al.  Measuring psychological resilience to disasters: are evidence-based indicators an achievable goal? , 2013, Environmental Health.

[63]  P. Manfredi,et al.  Modeling the interplay between human behavior and the spread of infectious diseases , 2013 .

[64]  C. Katz,et al.  The perspective of psychosocial support a decade after Bam earthquake: achievements and challenges. , 2013, The Psychiatric clinics of North America.

[65]  G. Koob.  Addiction is a Reward Deficit and Stress Surfeit Disorder , 2013, Front. Psychiatry.

[66]  Jennifer D Twilla,et al.  Sudden Cardiac Arrest in a Patient on Chronic Methadone After the Addition of Azithromycin , 2013, The American journal of the medical sciences.

[67]  A. Haghdoost,et al.  Effects of Methadone on Liver Enzymes in Patients Undergoing Methadone Maintenance Treatment , 2012, Addiction & health.

[68]  M. Amore,et al.  Psychobiological responses to unpleasant emotions in cannabis users , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[69]  Jing Ma,et al.  Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic Infections , 2011, Journal of Neuroimmune Pharmacology.

[70]  A. Baldacchino,et al.  Staff regard towards working with substance users: a European multi-centre study. , 2011, Addiction.

[71]  Michael E. Levin,et al.  Burnout among the addiction counseling workforce: the differential roles of mindfulness and values-based processes and work-site factors. , 2011, Journal of substance abuse treatment.

[72]  A. Velayati,et al.  Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection , 2011, Annals of thoracic medicine.

[73]  L. Manchikanti,et al.  A comprehensive review of opioid-induced hyperalgesia. , 2011, Pain physician.

[74]  C. Merlo,et al.  Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users , 2011, International journal of chronic obstructive pulmonary disease.

[75]  I. Maremmani,et al.  Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment. , 2010, The American journal on addictions.

[76]  Rosie P Cornish,et al.  Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database , 2010, BMJ : British Medical Journal.

[77]  A. Świergiel,et al.  Cocaine administration increases CD4/CD8 lymphocyte ratio in peripheral blood despite lymphopenia and elevated corticosterone. , 2010, International immunopharmacology.

[78]  C. Harrington,et al.  Buprenorphine Maintenance Therapy Hinders Acute Pain Management in Trauma , 2010, The American surgeon.

[79]  W. Hall,et al.  Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. , 2009, Drug and alcohol dependence.

[80]  Paul S Haber,et al.  Management of injecting drug users admitted to hospital , 2009, The Lancet.

[81]  G. Koob,et al.  Brain stress systems in the amygdala and addiction , 2009, Brain Research.

[82]  G. Reisfield,et al.  'False-positive' and 'false-negative' test results in clinical urine drug testing. , 2009, Bioanalysis.

[83]  W. Haefeli,et al.  Efavirenz treatment and false-positive results in benzodiazepine screening tests. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  N. Freudenberg,et al.  Nowhere to go: How stigma limits the options of female drug users after release from jail , 2009, Substance abuse treatment, prevention, and policy.

[85]  E. Chitsaz,et al.  Drug abuse profile – patient delay, diagnosis delay and drug resistance pattern – among addict patients with tuberculosis , 2009, International journal of STD & AIDS.

[86]  G. Koob.  A Role for Brain Stress Systems in Addiction , 2008, Neuron.

[87]  P. Sacerdote,et al.  Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function , 2008, Brain, Behavior, and Immunity.

[88]  N. Lee,et al.  A systematic review of cognitive and behavioural therapies for methamphetamine dependence. , 2008, Drug and alcohol review.

[89]  M. V. van Dongen,et al.  Prescription of benzodiazepines in general practice in the context of a man-made disaster: a longitudinal study. , 2007, European journal of public health.

[90]  J. van der Zee,et al.  Prospective cohort study into post-disaster benzodiazepine use demonstrated only short-term increase. , 2007, Journal of clinical epidemiology.

[91]  I. Higginson,et al.  The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. , 2007, Journal of pain & palliative care pharmacotherapy.

[92]  S. Galea,et al.  Stigma, discrimination and the health of illicit drug users. , 2007, Drug and alcohol dependence.

[93]  N. Mueller,et al.  Methadone-induced Torsade de pointes after stopping lopinavir–ritonavir , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[94]  Erika B. Litvin,et al.  Relapse and relapse prevention. , 2007, Annual review of clinical psychology.

[95]  C. Roussos,et al.  Acute cardiomyopathy and cardiogenic pulmonary edema after inhaled heroin use , 2007, Acta anaesthesiologica Scandinavica.

[96]  I. Higginson,et al.  The Use of Opioid Analgesia in End-Stage Renal Disease Patients Managed Without Dialysis , 2007 .

[97]  Robert G. Maunder,et al.  Long-term Psychological and Occupational Effects of Providing Hospital Healthcare during SARS Outbreak , 2006, Emerging infectious diseases.

[98]  S. Galea,et al.  Determinants of influenza vaccination in hard-to-reach urban populations. , 2006, Preventive medicine.

[99]  I. Grant,et al.  Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine. , 2006, Clinical chemistry.

[100]  Mohammad Reza Mohammadi,et al.  Changes in the use of opioid drugs and available interventions in Bam during the first year after the earthquake , 2006 .

[101]  J. Mao.  Opioid-induced abnormal pain sensitivity , 2006, Current pain and headache reports.

[102]  W. Ling,et al.  A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. , 2006, Addiction.

[103]  Jason M. White,et al.  Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations , 2006, Pain.

[104]  J. Abbas,et al.  Prevalence of Hepatitis B and C Infections and Their Associated Risk Factors in Addict Prisoners of Central Provinces of Iran , 2005 .

[105]  F. Lowy,et al.  Bacterial infections in drug users. , 2005, The New England journal of medicine.

[106]  R. Woosley,et al.  QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system , 2005, Pharmacoepidemiology and drug safety.

[107]  Y. Amitai,et al.  Water-Pipe (Narghile) Smoking: An Emerging Health Risk Behavior , 2005, Pediatrics.

[108]  A. Bertolini,et al.  Methadone--metabolism, pharmacokinetics and interactions. , 2004, Pharmacological research.

[109]  J. O’Connell.  Dying in the shadows: the challenge of providing health care for homeless people , 2004, Canadian Medical Association Journal.

[110]  S. Galea,et al.  The association between multiple domains of discrimination and self-assessed health: a multilevel analysis of Latinos and blacks in four low-income New York City neighborhoods. , 2003, Health services research.

[111]  S. Sampaio,et al.  Nephropathy associated with heroin abuse in Caucasian patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[112]  I. Kamel,et al.  Severe intraoperative hypertension and opioid-resistant postoperative pain in a methadone-treated patient. , 2003, The journal of pain : official journal of the American Pain Society.

[113]  R. Rawson,et al.  Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions. , 2003, Journal of consulting and clinical psychology.

[114]  N. Goeders.  The impact of stress on addiction , 2003, European Neuropsychopharmacology.

[115]  Kristine H. Luce,et al.  Computer- and Internet-Based Psychotherapy Interventions , 2003 .

[116]  P. Mehler,et al.  Torsade de Pointes Associated with Very-High-Dose Methadone , 2002, Annals of Internal Medicine.

[117]  Keith C. Norris,et al.  Cocaine use, hypertension, and end-stage renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[118]  Jason M. White,et al.  Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine , 2001, Pain.

[119]  W. Ling,et al.  Pain responses in methadone-maintained opioid abusers. , 2000, Journal of pain and symptom management.

[120]  P. Whelton,et al.  Risk of end-stage renal disease associated with alcohol consumption. , 1999, American journal of epidemiology.

[121]  N. Scherbaum,et al.  Profound Increase in Epinephrine Concentration in Plasma and Cardiovascular Stimulation after [micro sign]‐Opioid Receptor Blockade in Opioid‐addicted Patients during Barbiturate‐induced Anesthesia for Acute Detoxification , 1998, Anesthesiology.

[122]  T. Rhodes.  Risk theory in epidemic times: sex, drugs and the social organisation of ‘risk behaviour’ , 1997 .

[123]  D. D. Des Jarlais,et al.  Tuberculosis in drug users. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[124]  W. Ling,et al.  An intensive outpatient approach for cocaine abuse treatment. The Matrix model. , 1995, Journal of substance abuse treatment.

[125]  E. Bartoli,et al.  Renal tubular dysfunction in chronic alcohol abuse--effects of abstinence. , 1993, The New England journal of medicine.

[126]  P. Strong,et al.  Epidemic psychology: a model , 1990 .

[127]  P. Duell.  Chronic cocaine abuse and dilated cardiomyopathy. , 1987, The American journal of medicine.

[128]  J. Helderman,et al.  Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T's and Blues abusers. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[129]  J. Sharff.  Renal infarction associated with intravenous cocaine use. , 1984, Annals of emergency medicine.

[130]  M. E. O'Neill,et al.  Acute amphetamine cardiomyopathy in a drug addict , 1983, Clinical cardiology.

[131]  Michael John Smith,et al.  Voluntary versus prescribed termination of methadone maintenance. , 1978, The British journal of addiction to alcohol and other drugs.

[132]  M. Ginsberg,et al.  Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. , 1970, Annals of internal medicine.

[133]  T. Bewley.  Forensic Medicine and Toxicology: Drug Addiction , 1967, British medical journal.

[134]  J. Musser,et al.  The American Journal of Medical Sciences , 1847, Illinois and Indiana Medical and Surgical Journal.

[135]  Gang Chen,et al.  Epidemiological and clinical characteristics of SARS-CoV-2 and SARS-CoV: a system review , 2020 .

[136]  S. Boyd,et al.  Community Engagement - The Harms of Drug Prohibition: Ongoing Resistance in Vancouver’s Downtown Eastside , 2018 .

[137]  P. Corrigan,et al.  The Stigmatization of Drug Use as Mechanism of Legitimation of Exclusion , 2018 .

[138]  M. Stitzer,et al.  Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. , 2017, Journal of substance abuse treatment.

[139]  M. Özdal,et al.  Effect of Smoking on Oxygen Saturation in Healthy Sedentary Men and Women , 2017 .

[140]  Mahsa Jafari Giv.  Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC) , 2016, Cardiovascular Toxicology.

[141]  O. Abodunde,et al.  Cannabinoid Hyperemesis Syndrome Presenting With Recurrent Acute Renal Failure , 2013 .

[142]  A. Uchtenhagen.  Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence , 2009 .

[143]  T. Rushton,et al.  Right-sided infective endocarditis due to methicillin-resistant Staphylococcus aureus in an injecting drug user: outbreak or slow epidemic? , 2009, West Virginia Medical Journal.

[144]  G. Bagby,et al.  Alcohol abuse, immunosuppression, and pulmonary infection. , 2008, Current drug abuse reviews.

[145]  R. Maunder,et al.  Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak. , 2008, Psychiatric services.

[146]  S. Abram.  Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrationsAthanasos P, Smith CS, White JM, et al (Univ of Adelaide, SA, Australia; Royal Adelaide Hosp, SA, Australia; Univ of California, Los Angeles) Pain 120:267–275, 2006§ , 2007 .

[147]  F. Goodarzi,et al.  A survey on changes in opioid use and risk factors in the survivors eight months after Bam earthquake , 2006 .

[148]  Rahimi Movaghar Afarin,et al.  THE PREVALENCE OF POSTTRAUMATIC STRESS DISORDER AND ITS SYMPTOMS AMONG BAN EARTHQUAKE SURVIVORS , 2006 .

[149]  Rahimi Movaghar Afarin,et al.  A SURVEY ON CHANGES IN OPIOID USE AND RISK FACTORS IN BAM EARTHQUAKE SURVIVORS , 2006 .

[150]  C. Gilpin,et al.  A cluster of tuberculosis associated with use of a marijuana water pipe. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[151]  T. Tena,et al.  High concentration of chloroquine in urine gives positive result with Amphetamine CEDIA reagent. , 2002, Journal of analytical toxicology.

[152]  K. Merigian,et al.  Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. , 1987, Journal of toxicology. Clinical toxicology.

[153]  J. Brentjens,et al.  Heroin nephropathy. A clinicopathologic and epidemiologic study. , 1980, The American journal of medicine.

[154]  S. Rifkin.  Amphetamine-induced angiitis leading to renal failure. , 1977, Southern medical journal (Birmingham, Ala. Print).

[155]  Rifkin Si.  Amphetamine-induced angiitis leading to renal failure. , 1977 .

[156]  H. Mösslacher.  [Alcoholic cardiomyopathy]. , 1973, Wiener klinische Wochenschrift. Supplementum.

[157]  P. Blachly.  Management of the opiate abstinence syndrome. , 1966, The American journal of psychiatry.